T1	Participants 129 154	nasopharyngeal carcinoma.
T2	Participants 254 278	nasopharyngeal carcinoma
T3	Participants 585 709	749 patients who underwent MRI and were subsequently histologically diagnosed with nondisseminated NPC and treated with IMRT
T4	Participants 1525 1542	patients with NPC
